basiliximab (Simulect) Report issue

Biologics mAb Orphan Drug FDA Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA MeSH repoDB
Back

Drug Pricing Summary

VA Big4

$2028.8800 - $2644.4500

VA FSS

$2948.1900 - $3869.5000

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
basiliximab 10 mg / 2.5 mL (2.5 mL INJECTION) $2028.8800 VA Big4
  • Simulect (1)
    		•  Novartis Pharmaceuticals Corporation
    basiliximab 10 mg / 2.5 mL (2.5 mL INJECTION) $2948.1900 VA FSS
  • Simulect (1)
    		•  Novartis Pharmaceuticals Corporation
    basiliximab 20 mg / 5 mL (5 mL INJECTION) $2644.4500 VA Big4
  • Simulect (1)
    		•  Novartis Pharmaceuticals Corporation
    basiliximab 20 mg / 5 mL (5 mL INJECTION) $3869.5000 VA FSS
  • Simulect (1)
    		•  Novartis Pharmaceuticals Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue